Contineum Therapeutics, Inc. (CTNM)
Market Open
1 Sep, 19:45
NASDAQ (NGS) NASDAQ (NGS) Primary $
16. 62
+0.39
+2.3707%
$
610.97M Market Cap
- P/E Ratio
- Div Yield
147,495 Volume
- Eps
$ 16.24
Previous Close Investors:
Want to track CTNM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
CTNM Earnings Reports FAQ
What is the earnings per share (EPS) for CTNM?
EPS data for CTNM is currently not available, as Contineum Therapeutics, Inc has not reported recent earnings.
What is the company's earnings growth rate?
Contineum Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Contineum Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Contineum Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for CTNM at this time, as Contineum Therapeutics, Inc has no recent EPS data to calculate it.
